In This Article:
Over the last 7 days, the United Kingdom market has dropped 1.3%, but it remains up 8.3% over the past year with earnings projected to grow by 14% annually in the coming years. In this context, growth companies with substantial insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, potentially driving robust performance even in fluctuating markets.
Top 10 Growth Companies With High Insider Ownership In The United Kingdom
| Name | Insider Ownership | Earnings Growth |
| Integrated Diagnostics Holdings (LSE:IDHC) | 27.6% | 23.7% |
| Helios Underwriting (AIM:HUW) | 23.9% | 16.1% |
| Foresight Group Holdings (LSE:FSG) | 31.7% | 27.9% |
| LSL Property Services (LSE:LSL) | 10.8% | 33.3% |
| Belluscura (AIM:BELL) | 36.1% | 113.4% |
| B90 Holdings (AIM:B90) | 24.4% | 142.7% |
| Velocity Composites (AIM:VEL) | 27.6% | 188.7% |
| Judges Scientific (AIM:JDG) | 11.9% | 26.9% |
| Gulf Keystone Petroleum (LSE:GKP) | 12.1% | 80.6% |
| Evoke (LSE:EVOK) | 20.5% | 105.2% |
Here we highlight a subset of our preferred stocks from the screener.
Craneware
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Craneware plc, with a market cap of £828.40 million, develops, licenses, and supports computer software for the healthcare industry in the United States.
Operations: The company's revenue segment includes Healthcare Software, which generated $189.27 million.
Insider Ownership: 17%
Craneware's revenue is forecast to grow at 8.2% per year, outpacing the UK market's 3.7%. Earnings are expected to rise significantly at 25.6% annually, surpassing the market average of 14.4%. Recent earnings showed a net income increase to US$11.7 million from US$9.23 million last year, and Craneware is actively seeking acquisitions while expanding its collaboration with Microsoft Azure for enhanced cloud capabilities and AI integration in healthcare solutions.
-
Take a closer look at Craneware's potential here in our earnings growth report.
-
Our valuation report here indicates Craneware may be overvalued.
Judges Scientific
Simply Wall St Growth Rating: ★★★★★☆
Overview: Judges Scientific plc designs, manufactures, and sells scientific instruments with a market cap of £703.98 million.
Operations: The company generates revenue from two main segments: Vacuum (£63.60 million) and Materials Sciences (£72.50 million).
Insider Ownership: 11.9%
Judges Scientific's revenue is forecast to grow at 6.3% annually, outpacing the UK market's 3.7%. Earnings are expected to rise significantly at 26.88% per year, with a high forecasted return on equity of 20.9%. Despite recent volatility and lower profit margins (7%) compared to last year (11%), the appointment of Dr. Ian Wilcock as Group Commercial Director brings extensive leadership and innovation experience, potentially driving future growth and development initiatives within the company.